Isothermal Nucleic Acid Amplification Technology (INAAT) Market - Growth, Trends, and Forecast (2020 - 2025)

The market is segmented by Technology, Product, End-User (Hospital, Diagnostic Laboratories, Research laboratories), and Geography

Market Snapshot

Study Period:


Base Year:


Fastest Growing Market:

Asia Pacific

Largest Market:

North America

Major Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

Increasing incidences of chronic diseases and aging population, increase in the adoption of INAAT over PCR, and rise in demand for low-cost and effective diagnostics procedures are some of the major factors that are driving the growth of the market studied.

Nucleic acid amplification has several applications in the healthcare industry starting from research to clinics. Until now, PCR has been the most widely-used amplification technology across the world. A thermal cycler is required in PCR, as various temperatures need to be maintained at different steps of the amplification process. Additionally, contaminants must be removed for effective amplification through this technology. The thermal cycler itself is costly, and sample preparation to remove contaminants from the sample makes the overall process more costly and time-consuming.

Owing to this high cost, the technique has witnessed limited adoption in developing countries, where the demand for this technology is extremely high, especially for clinical application. This high demand has led to the development of novel innovative techniques, such as isothermal nucleic acid amplification technology.

The isothermal technique, as the name suggests, is performed at a fixed temperature. This temperature can vary depending on the type of nucleic acid. The tedious task of preparing a sample is not required, as the technology can take a sample directly for amplification. Additionally, the technology is affordable, making it accessible for people belonging to different economic levels across the world. The low-cost associated with technology is likely to result in increased adoption, especially in the developing regions.

Hence, owing to the cost benefits and the use of novel technologies, INAAT market is expected to grow in the coming future.

Scope of the Report

Nucleic acid amplification technologies are used in the field of molecular biology and recombinant DNA technologies. These techniques are used as leading methods in detecting and analyzing a small number of nucleic acids. Isothermal nucleic acid amplification technology protocols are varied, and have many advantages, as it is extremely fast and do not require thermocyclers.

By Technology
Helicase-dependent Amplification (HDA)
Nicking Enzyme Amplification Reaction (NEAR)
Loop-mediated Isothermal Amplification (LAMP)
Strand Displacement Amplification (SDA)
Nucleic Acid Sequence-based Amplification (NASBA)
Transcription Mediated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Other Technologies
By Product
By End-User
Diagnostic Laboratories
Research Laboratories
North America
Rest of Europe
Asia Pacific
South Korea
Rest of Asia-Pacific
Middle East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Loop-mediated Isothermal Amplification (LAMP) to Witness Fastest Growth Over the Forecast Period

Loop-mediated isothermal amplification (LAMP) test is the most widely used technique, and its usage is expected to grow rapidly during the forecast period. In this technique, a minimum of four sets of primers are used, two outer primers and two inner primers. There are various software's that are available for primer designing, such as primer explorer, LAMP designer, and other software. These loop primers bind to the nucleic acid template and further accelerate the reaction. The technique can be used for amplification of both, DNA and RNA.

Since its inception in the early 2000s,  LAMP tests have been developed for a variety of disease-causing agents, due to its capability of amplifying both DNA and RNA. Additionally, the tests can be used for the identification of genetically modified organisms.

This technique has two major competitive advantages over the PCR technology. First, the LAMP test is tolerant of PCR inhibitors, which makes it well-suited for direct analysis of the sample. Secondly, there is no need of thermocycler, as it is performed at a fixed temperature. These two advantages make it useful in point-of-care diagnostics. As the market for point-of-care diagnostics is growing, the LAMP segment of the market studied is also likely to grow proportionally.

To understand key trends, Download Sample Report

North America to Dominate the Market

North America dominates the Isothermal Nucleic Acid Amplification Technology (INAAT) market, owing to a high incidence of chronic diseases, technological advancement in isothermal nucleic acid amplification technology (INAAT), and increasing adoption of INAAT over conventional techniques in the region. The Asia Pacific is expected to grow during the forecast period, owing to factors, such as high demand in cost-effective and diagnostics, less stringent regulatory scenario, and the presence of a huge population base.

To understand geography trends, Download Sample Report.

Competitive Landscape

The market studied is moderately competitive and consists of global players such as Becton Dickinson and Company, Qiagen NV, bioMerieux, etc. With the rising use of INAA Technology across the developing countries, it is expected that few local players in countries like China, India, etc. will penetrate the market in the near future. However, the largest share of this market is grabbed by the global players as of now.

Table Of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidences of Chronic Diseases And Aging Population

      2. 4.2.2 Increase in the Adoption of INAAT Over PCR

      3. 4.2.3 Rise In The Miniaturization of Nucleic Acid-based Diagnostics

      4. 4.2.4 Rise In Demand for Low-cost And Effective Diagnostics Procedures

    3. 4.3 Market Restraints

      1. 4.3.1 Threatening Opposition from PCR Technologies

      2. 4.3.2 Lack of Awareness about New Diagnostics Technologies

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Technology

      1. 5.1.1 Helicase-dependent Amplification (HDA)

      2. 5.1.2 Nicking Enzyme Amplification Reaction (NEAR)

      3. 5.1.3 Loop-mediated Isothermal Amplification (LAMP)

      4. 5.1.4 Strand Displacement Amplification (SDA)

      5. 5.1.5 Nucleic Acid Sequence-based Amplification (NASBA)

      6. 5.1.6 Transcription Mediated Amplification (TMA)

      7. 5.1.7 Single Primer Isothermal Amplification (SPIA)

      8. 5.1.8 Other Technologies

    2. 5.2 By Product

      1. 5.2.1 Instruments

      2. 5.2.2 Reagents

    3. 5.3 By End-User

      1. 5.3.1 Hospitals

      2. 5.3.2 Diagnostic Laboratories

      3. 5.3.3 Research Laboratories

    4. 5.4 Geography

      1. 5.4.1 North America

        1. US

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. UK

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Becton, Dickinson & Company

      2. 6.1.2 bioMerieux

      3. 6.1.3 Eiken Chemical Co. Ltd

      4. 6.1.4 Lucigen

      5. 6.1.5 Meridian Bioscience

      6. 6.1.6 Tecan Genomics Inc.

      7. 6.1.7 OptiGene Limited

      8. 6.1.8 Qiagen

      9. 6.1.9 Quidel Corporation

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

Related Reports